Szmit S, Jędrzejczak WW, Opolski G. Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardiovascular diseases. OncoReview [Internet]. 2013Oct.1 [cited 2024May16];3(3(11):213-5. Available from: https://journalsmededu.pl/index.php/OncoReview/article/view/345